-
Product Insights
New![]()
Samlong Coal Mine (Small Scale)
The Samlong Coal Mine (Small Scale) is a coal mine in Myanmar. It is currently in operation. Empower your strategies with our Samlong Coal Mine (Small Scale) report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance....
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Cellular Immunotherapy for Non-Small Cell Lung Cancer in Non-Small Cell Lung Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Cellular Immunotherapy For Non-Small Cell Lung Cancer in Non-Small Cell Lung Cancer Drug Details:Cellular immunotherapy is...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Cellular Immunotherapy For Non-Small Cell Lung Cancer in Non-Small Cell Lung Cancer
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Cellular Immunotherapy For Non-Small Cell Lung Cancer in Non-Small Cell Lung Cancer Drug Details:...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Gene Therapy To Target Egfr For Non Small Cell Lung Cancer in Non-Small Cell Lung Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Gene Therapy To Target Egfr For Non Small Cell Lung Cancer in Non-Small Cell Lung CancerDrug...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Pacmilimab in Small Intestine Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Pacmilimab in Small Intestine Cancer Drug Details: CX-072 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Small Molecule Drugs in Seizures
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Small Molecule Drugs in SeizuresDrug Details:The drug candidates are under development for the treatment of drug-resistant...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Pembrolizumab in Small Intestine Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Pembrolizumab in Small Intestine Cancer Drug Details: Pembrolizumab (Keytruda) is an antineoplastic immunomodulating agent. Keytruda...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Selpercatinib in Small Intestine Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Selpercatinib in Small Intestine CancerDrug Details: Selpercatinib (Retevmo, Retsevmo) is a potent antineoplastic agent. It is...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Dostarlimab in Small-Cell Lung Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Dostarlimab in Small-Cell Lung Cancer Drug Details: Dostarlimab (Jemperli) is a immunoglobulin G4 humanized monoclonal...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Surufatinib in Small-Cell Lung Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Surufatinib in Small-Cell Lung Cancer Drug Details: Surufatinib (Sulanda) is a potential antineoplastic and anti-angiogenic...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.